An observational study in People Incarcerated and COVID-19, sponsored by University Hospital, Montpellier. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-12-29.
Sponsored by University Hospital, Montpellier · Observational
The SARS-CoV 2 pandemic started in China in December 2019, then reached France on January 24, 2020.
On March 14, France moved into phase 3 of the epidemic threshold with the implementation of containment measures on March 17 Measures were put in place by N.Belloubet (French Minister of Justice) from March 17, including suspension of visiting rooms and activities in detention.
Containment provides boredom and isolation with many potential consequences: sleep disturbance, anxiety, PTSD, depression, suicide, addictive behavior and violence.
However,prisoners have a higher prevalence of substance use disorders than the general population.
What will have been the impact of the confinement on the consumption of psychoactive substances by prisoners at the Villeneuve Les Maguelone prison.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 700 is above the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.
Counted across the registry records on this site, refreshed daily.
People incarcerated in Villeneuve-Lès-Maguelon prison
Exclusion criteria:
percentage changes in the consumption of psychoactive substances
percentage changes in the consumption of psychoactive substances
Time frame: 1 day
Assessment of the level of stress
Assessment of the level of stress by self-administered questionnaire before / during confinement
Time frame: 1 day
Assessment of depression
Assessment of depression by self-administered questionnaire before / during confinement
Time frame: 1 day
Craving modification evaluation
Craving modification evaluation
Time frame: 1 day
Plan to share: Undecided — NC
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier